Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.50
Bid: 103.00
Ask: 108.00
Change: -0.50 (-0.47%)
Spread: 5.00 (4.854%)
Open: 105.50
High: 105.00
Low: 105.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

8 Dec 2009 07:00

RNS Number : 7212D
Intercede Group PLC
08 December 2009
 



DECEMBER 2009

INTERCEDE GROUP plc

('Intercede', 'the Company' or 'the Group')

Interim Results for the 6 Months Ended 30 September 2009

Intercede (AIM: IGP.L) is a leading producer of Identity and Credential Management software, called MyID, which manages the secure registration, issuance and life cycle of digital identities for a wide range of uses. 

SUMMARY

- 42% increase in sales to £2,811,000 (2008: £1,981,000).

- Operating profit before exceptional items of £674,000 (2008: £268,000).

- Profit before tax of £85,000 (2008: £222,000).

- Cash inflow of £202,000 (2008: £686,000).

- Cash balances of £3,913,000 at 30 September 2009 (30 September 2008: £1,839,000).

- All external borrowings eliminated following the decision of the convertible loan note holders to convert their loan notes into ordinary shares.

- Release of MyID 8 SR1, a major upgrade to the MyID platform.

- Successful deployment of MyID into two National ID schemes that have entered 'live' production.

- Continued expansion of Intercede's customer base in the US in partnership with VeriSign.

- Winning new contracts to supply MyID to government ministries, banks and business corporations around the world.

- Intercede overtakes competitors to be No1 in class as measured by the number of contract wins announced during the period.

Richard Parris, Chairman & Chief Executive of Intercede, said today:

"Our performance continues to grow in line with our expectations. Intercede has now  delivered  three consecutive half year periods of profitability as a result of substantial  revenue growthThis growth is driven by a combination of recurring sales to existing installations, demand from new customers and an expansion of both our product scope and geographical reach.  We remain  very excited about the size and scope of contracts we are working on and the potential of our strongest ever sales pipeline."

  ENQUIRIES

Intercede Group plc

Tel.+44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

FinnCap

Charles Cunningham

Tel. +44 (0)20 7600 1658

Pelham Public Relations

Archie Berens

Tel.+44 (0)20 7337 1509

Francesca Tuckett

Tel.+44 (0)20 7337 1537

About Intercede

Intercede is the producer of the MyID® Identity and Credential Management System (IDCMS). Intercede's MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing: secure registration, biometric capture, application vetting and approval through to smart card personalization, issuance and management.

Intercede's MyID is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 10 Federal Agencies, a programme with Lockheed Martin and two major US financial institutions. In Europe and the Middle East, Intercede's MyID is being deployed in support of government identity, health and corporate employee ID security projects.

Intercede and MyID are registered trademarks or trademarks in the UK, US and/or other countries.

For more information visit  http://www.intercede.com.

  INTERCEDE GROUP plc

Interim Results for the Six Months Ended 30 September 2009

Chairman's Statement

Introductio

I am pleased to be able to report that excellent commercial and technical progress has been made during the first half of the year. Revenues have increased by 42% to £2,811,000 (2008: £1,981,000), resulting in an operating profit before exceptional items of £674,000 compared to £268,000 in the same period last year.

As a result of this improved performance and careful cash management, cash balances at 30 September 2009 totaled £3,913,000, which compares to £3,711,000 at 31 March 2009 and £1,839,000 at 30 September 2008. All external borrowings have also been eliminated during the period following the decision of the convertible loan note holders to convert their loan notes into ordinary shares.

This represents a turning point in the evolution of Intercede's business and is indicative of the strong commercial progress we continue to make.

Commercial Progress

Significant advances during the year to date include:

Successful commissioning of two National ID schemes powered by MyID; one in Kuwait and the other for an undisclosed government customer.

Winning new US Federal and State government customers in partnership with VeriSign. 

Securing MyID sales with a Middle Eastern oil company, manufacturing companies in  Austria and Switzerland, government ministries in Romania and Slovakiaand banks in  Australiathe Czech RepublicScandinavia and the Ukraine.

Winning a contract with a major security printing and smart card manufacturer for issuing identity cards to their employees at facilities around the world.

Selling an additional 100,000 MyID licenses to BT for the NHS Data Spine project which takes the total sold to date up to 700,000.

Securing additional orders totaling in excess of $1.0m for MyID software licenses and professional services in support of the internal identity badge of the world's largest defence contractor, Lockheed Martin.

Supporting Lockheed Martin on the US Transportation Worker Identity Credential (TWIC) program which has to date resulted in the issuance of 1.3 million cards to US dock workers using MyID.

Worked with a US partner to win a multi-year contract to supply MyID to a large US based, global management consultancy group for internal security and regulatory compliance.

The addition of the US Social Security Administration (SSA) to Intercede's HSPD-12 customer list.

The deployment of MyID 8 SR1 to two existing US Air Force base customers.

Following the successful launch of MyID 8 in June 2008, which repositioned MyID from being a smart card management system to a fully featured Identity and Credential Management System, MyID 8 SR1 was released on 26 October 2009. This updated version includes support for a wide range of third party systems and devices and enables partners and systems integrators to add value faster using Intercede's revolutionary Project Designer suite of Application Programming Interfaces (APIs) and customisation tools.

Financial Results

The financial results reflect the continued momentum from the Group's involvement in an increasing number of projects around the world.

Sales increased by 42% to £2,811,000 (2008: £1,981,000) which resulted in a substantial increase in operating profit before exceptional items from £268,000 to £674,000. Exceptional costs incurred during the period as a result of the ActivIdentity patent infringement lawsuit outlined below totaled £579,000 (2008: £nil). 

Staff costs continue to represent the main area of expense representing approximately 80% of the total operating costs excluding exceptional itemsThe average number of employees increased from 44 to 54 year on year.

A profit for the period of £85,000 (2008: £283,000) resulted in a basic earnings per share of 0.2p (2008: 0.8p) and a fully diluted earnings per share of 0.2p (2008: 0.6p). Adjusting for the exceptional costs results in a fully diluted pre exceptional earnings per share of 1.4p (2008: 0.6p). 

Cash balances at 30 September 2009 totaled £3,913,000 (2008: £1,839,000) and were therefore more than double that of a year ago, notwithstanding the exceptional legal costs incurred to date as a result of the ActivIdentity patent infringement lawsuit. During the period, the Group's financial position has also been substantially strengthened following the decision of all of the convertible loan note holders to convert their loan notes into ordinary shares.

Intellectual Property

The reported period includes exceptional costs for defending a previously reported patent infringement case which was filed in the US by ActivIdentity Corporation on 1 October 2008. Intercede's answer and counterclaims deny that its products infringe ActivIdentity's patent and allege further that this patent is invalid and unenforceable. In addition, Intercede has filed counterclaims against ActivIdentity alleging violations of US antitrust law. Intercede intends to pursue its defence and its counterclaims vigorously.

Outlook

The first half of the year has been profitable and cash generative. As in previous years, the full year outcome will be dependent upon the timing of receipt of orders and our subsequent ability to deliver and recognise revenues in accordance with the Group's accounting policy. Nevertheless, the level and pace of customer and partner activity is greater than in previous periods and the sales pipeline is stronger than ever. therefore remain confident that our operating performance will continue to meet expectations.

Richard Parris

Chairman & Chief Executive

8 December 2009

  Intercede Group plc

Consolidated Statement of Comprehensive Income

6 months ended

6 months ended

Year ended

30 September

30 September

31 March

2009

2008

2009

£'000

£'000

£'000

Continuing operations

Revenue

2,811

1,981

5,701

Cost of sales

(73)

(25)

(41)

 

Gross profit

2,738

1,956

5,660

Administrative expenses

(2,643)

(1,688)

(4,173)

 

Operating profit

95

268

1,487

Operating profit before exceptional item

674

268

1,858

Exceptional item

(579)

-

(371)

 

Operating profit

95

268

1,487

Finance income

16

28

68

Finance costs

(26)

(74)

(147)

 

Profit before tax

85

222

1,408

Tax

-

61

341

 

Profit for the period

85

283

1,749

Total comprehensive income attributable to owners of the company

85

283

1,749

Earnings per share (pence)

- basic 

0.2p

0.8p

4.7p

- diluted 

0.2p

0.6p

3.6p

  Intercede Group plc

Consolidated Balance Sheet

As at

As at

As at

30 September

30 September

31 March

2009

2008

2009

£'000

£'000

£'000

Non-current assets

Property, plant and equipment

70

57

67

Deferred tax

280

-

280

350

57

347

Current assets

Trade and other receivables

687

866

902

Cash and cash equivalents

3,913

1,839

3,711

 

4,600

2,705

4,613

Total assets

4,950

2,762

4,960

Equity

Called up share capital

4,413

4,302

4,305

Share premium account

4,718

2,834

2,875

Other reserves

1,508

1,508

1,508

Equity reserve

-

109

109

Retained earnings

(7,908)

(9,568)

(8,102)

 

Total equity

2,731

(815)

695

Current liabilities

Trade and other payables

1,025

493

1,156

Deferred revenue

1,194

1,177

1,173

Convertible loan notes

-

1,907

1,936

 

2,219

3,577

4,265

 

Total equity and liabilities

4,950

2,762

4,960

  Intercede Group plc

Consolidated Statement of Changes in Equity

Share 

Share 

Other 

Equity 

Retained 

Capital

Premium

reserves

reserve

earnings

Total

£'000

£'000

£'000

£'000

£'000

£'000

At 31 March 2009

4,305

2,875

1,508

109

(8,102)

695

Issue of shares, net of costs

108

1,843

-

-

-

1,951

Loan note conversion - reversal of FRS25 equity component

-

-

-

(109)

109

-

Total comprehensive income

-

-

-

-

85

85

At 30 September 2009

4,413

4,718

1,508

-

(7,908)

2,731

At 31 March 2008

4,292

2,764

1,508

109

(9,851)

(1,178)

Issue of shares, net of costs 

10

70

-

-

-

80

Total comprehensive income

-

-

-

-

283

283

 

 

 

 

 

 

At 30 September 2008

4,302

2,834

1,508

109

(9,568)

(815)

At 31 March 2008

4,292

2,764

1,508

109

(9,851)

(1,178)

Issue of shares, net of costs

13

111

-

-

-

124

Total comprehensive income

-

-

-

-

1,749

1,749

 

 

 

 

 

 

At 31 March 2009

4,305

2,875

1,508

109

(8,102)

695

  Intercede Group plc

Consolidated Cash Flow Statement

6 months ended

6 months ended

Year ended

30 September

30 September

31 March

2009

2008

2008

£'000

£'000

£'000

Cash flows from operating activities

Operating profit

95

268

1,487

Depreciation

15

12

25

Decrease/(increase) in trade and other receivables

214

(441)

(483)

(Decrease)/increase in trade and other payables

(111)

701

(1360)

Cash generated from operations

213

540

2,389

Taxation received

-

61

61

Net cash from operating activities

213

601

2,450

Investing activities

Interest received

18

22

68

Purchases of property, plant and equipment

(19)

(17)

(40)

 

Net cash from investing activities

(1)

5

28

Financing activities

(Cost)/proceeds on issue of shares

(10)

80

80

 

Net increase in cash and cash equivalents

202

686

2,558

Cash and cash equivalents at the start of the period

3,711

1,153

1,153

 

Cash and cash equivalents at the end of the period

3,913

1,839

3,711

  

Intercede Group plc

Notes to the Accounts

1. Preparation of the interim financial statements

These interim financial statements have been prepared under IFRS as adopted by the European Union and on the basis of the accounting policies set out in the Group's Annual Report for the year ended 31 March 2009.

The Group is not required to apply IAS 34 Interim Financial Reporting at this time.

These interim financial statements have not been audited and do not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 March 2009 have been delivered to the Registrar of Companies. The Auditors' Report on those accounts was unqualified and did not contain any statement under Section 498 (2) or (3) of the Companies Act 2006.

The Interim Report will be mailed to shareholders prior to the end of December 2009 and copies will be available on the website (www.intercede.com) and at the registered office: Intercede Group plc, Lutterworth Hall, St Mary's Road, Lutterworth, LeicestershireLE17 4PS.

2. Segmental Reporting

All of the Group's revenue, operating profits and net assets originate from operations in the United Kingdom. The Directors consider that the activities of the Group constitute a single business segment.

The split of revenue by geographical destination of the end customer can be analysed as follows:

6 months

ended

6 months

 ended

Year ended

30 September

30 September

31 March

2009

2008

2009

£'000

£'000

£'000

United Kingdom

795

882

2,488

Rest of Europe

806

380

846

USA

1,085

704

2,104

Rest of World

125

15

263

 

2,811

1,981

5,701

3. Exceptional item

The exceptional item, which is included within administrative expenses, represents the costs associated with defending a patent infringement lawsuit which was filed by ActivIdentity in the United States District Court for the Northern District of California on 1 October 2008.

No provision has been made as at 30 September 2009 in respect of the original ActivIdentity lawsuit or contingent asset disclosed in respect of Intercede's counterclaims.

4. Tax

There is no charge for corporation tax due to the availability of losses brought forward from prior years.

5. Earnings per share

The calculation of earnings per ordinary share is based on the profit and the weighted average number of ordinary shares in issue during each period i.e. September 200944,704,340; September 2008: 36,871,850 and March 200937,011,460. The diluted earnings per share is based on a weighted average of 48,735,005 ordinary shares  (September 2008 and March 2009: 48,785,009) which reflects the potential exercise of all existing share options. 

6. Dividend

The Directors do not recommend the payment of a dividend.

7. Analysis and reconciliation of net debt

 

 

 
6 months ended
6 months ended

Year ended

 
30 September
30 September
31 March
 
2009
2008
2009
 
£'000
£'000
£'000
 
 
 
 
Cash and cash equivalents
3,913
1,839
3,711
 
 
 
 
Convertible loan notes
-
(1,907)
(1,936)
 
 
 
 
Net cash/(debt)
3,913
(68)
1,775

On 29 May 2009, notification was received from the remaining holders of the convertible loan notes issued by the Company on 31 March 2000 and 6 December 2001 that they had elected to convert their loan notes together with associated interest for the period to 31 May 2009 into ordinary shares of 1p each in the Company. This resulted in the issue of 3,877,166 ordinary shares at a price of 15p per share and 6,897,083 ordinary shares at a price of 20p per share. Following the conversion, the total issued share capital of the Company is 48,178,005 ordinary shares of 1p each.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR ILFSRFLLDIIA
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.